seed
Stage
2
Investors
About
Tessella Biosciences develops ready-to-use bioinks and biopolymers for advanced 3D cell culture and bioprinting applications, enabling researchers to create reproducible 3D bioprinted constructs for tissue modeling and regenerative medicine.
Explore Tessella Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.